KRISTIN GRIGGS: Open Payments
NPI 1104475425 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 20 payments from 6 companies in 2025. Trend: 2023 $194 · 2024 $1,379 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $242 |
| Janssen Biotech, Inc. | 8 | $147 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: TREMFYA, SKYRIZI, RINVOQ, VOQUEZNA, ENTYVIO, REZDIFFRA, DUPIXENT, CREON.
Industry payments across GA — which companies pay providers there.
